Global Information
회사소개 | 문의 | 비교리스트

심방세동 치료 시장 : 세계 산업 동향, 점유율, 규모, 성장률, 기회, 예측(2020-2025년)

Atrial Fibrillation Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

리서치사 IMARC Services Private Limited
발행일 2020년 06월 상품 코드 945301
페이지 정보 영문 112 Pages
가격
US $ 2,299 ₩ 2,716,000 PDF by E-mail (Single User License)
US $ 3,399 ₩ 4,016,000 PDF by E-mail (5 User License)
US $ 4,499 ₩ 5,316,000 PDF by E-mail (Corporate License)


심방세동 치료 시장 : 세계 산업 동향, 점유율, 규모, 성장률, 기회, 예측(2020-2025년) Atrial Fibrillation Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025
발행일 : 2020년 06월 페이지 정보 : 영문 112 Pages

세계의 심방세동 치료 시장은 2014-2019년 약 14%의 CAGR로 성장했습니다. 시장 성장의 주요 요인으로 심혈관질환(CVD)의 유병률 상승, 저침습(MI) 외과수술의 인기 확대, 활발한 연구개발(R&D) 활동의 성과 등을 들 수 있습니다.

세계의 심방세동(AFib) 치료 시장 구조와 동향에 대해 분석했으며, 시장의 전체적 구조, 시장 규모의 추이·예측, 증상별·치료 유형별·최종사용자별·지역별 상세 동향, 시장의 매력·경쟁 상황, 주요 기업의 개요 등에 대해 조사하여 전해드립니다.

제1장 서론

제2장 분석 범위·방법

제3장 개요

제4장 서론

제5장 세계의 심방세동 치료 시장

  • 시장 개요
  • 시장 규모

제6장 증상 유형별 시장 내역

  • 발작성 심방세동
  • 지속성 심방세동
  • 영구성 심방세동
  • 기타

제7장 치료 유형별 시장 내역

  • 의료 시술
    • 외과적 시술
    • 비외과적 디바이스
  • 약리 요법
    • 약물 클래스

제8장 최종사용자별 시장 내역

  • 병원
  • 심장 검사실
  • 외래 수술 센터
  • 기타

제9장 지역별 시장 내역

  • 북미
    • 미국
    • 캐나다
  • 아시아태평양
    • 중국
    • 일본
    • 인도
    • 한국
    • 호주
    • 인도네시아
    • 기타
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 스페인
    • 러시아
    • 기타
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 기타
  • 중동·아프리카
    • 시장 분석 : 국가별

제10장 SWOT 분석

제11장 밸류체인 분석

제12장 Porter의 산업 분석

제13장 경쟁 환경

  • 시장 구조
  • 주요 기업
  • 주요 기업의 개요
    • Abbott Laboratories
    • Atricure Inc.
    • Biosense Webster Inc.
    • Biotronik
    • Cardiofocus Inc.
    • Hansen Medical Inc.(Auris Health)
    • Johnson & Johnson
    • Siemens Healthineers(Cerner Corporation)
    • Stereotaxis Inc.
KSA 20.07.14

List of Figures

  • Figure 1: Global: Atrial Fibrillation Market: Major Drivers and Challenges
  • Figure 2: Global: Atrial Fibrillation Market: Sales Value (in Billion US$), 2014-2019
  • Figure 3: Global: Atrial Fibrillation Market: Breakup by Disorder Type (in %), 2019
  • Figure 4: Global: Atrial Fibrillation Market: Breakup by Treatment Type (in %), 2019
  • Figure 5: Global: Atrial Fibrillation Market: Breakup by End-User (in %), 2019
  • Figure 6: Global: Atrial Fibrillation Market: Breakup by Region (in %), 2019
  • Figure 7: Global: Atrial Fibrillation Market Forecast: Sales Value (in Billion US$), 2020-2025
  • Figure 8: Global: Atrial Fibrillation (Paroxysmal Atrial Fibrillation) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 9: Global: Atrial Fibrillation (Paroxysmal Atrial Fibrillation) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 10: Global: Atrial Fibrillation (Persistent Atrial Fibrillation) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 11: Global: Atrial Fibrillation (Persistent Atrial Fibrillation) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 12: Global: Atrial Fibrillation (Permanent Atrial Fibrillation) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 13: Global: Atrial Fibrillation (Permanent Atrial Fibrillation) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 14: Global: Atrial Fibrillation (Others) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 15: Global: Atrial Fibrillation (Others) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 16: Global: Atrial Fibrillation (Medical Procedures) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 17: Global: Atrial Fibrillation Market (Medical Procedures): Breakup by Type (in %), 2019
  • Figure 18: Global: Atrial Fibrillation Market (Surgical Procedures): Breakup by Type (in %), 2019
  • Figure 19: Global: Atrial Fibrillation (Medical Procedures) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 20: Global: Atrial Fibrillation (Medication) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 21: Global: Atrial Fibrillation Market (Medication): Breakup by Drug Class (in %), 2019
  • Figure 22: Global: Atrial Fibrillation (Medication) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 23: Global: Atrial Fibrillation (Hospitals) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 24: Global: Atrial Fibrillation (Hospitals) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 25: Global: Atrial Fibrillation (Cardiac Labs) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 26: Global: Atrial Fibrillation (Cardiac Labs) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 27: Global: Atrial Fibrillation (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 28: Global: Atrial Fibrillation (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 29: Global: Atrial Fibrillation (Others) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 30: Global: Atrial Fibrillation (Others) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 31: North America: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 32: North America: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 33: United States: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 34: United States: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 35: Canada: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 36: Canada: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 37: Asia Pacific: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 38: Asia Pacific: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 39: China: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 40: China: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 41: Japan: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 42: Japan: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 43: India: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 44: India: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 45: South Korea: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 46: South Korea: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 47: Australia: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 48: Australia: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 49: Indonesia: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 50: Indonesia: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 51: Others: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 52: Others: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 53: Europe: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 54: Europe: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 55: Germany: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 56: Germany: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 57: France: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 58: France: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 59: United Kingdom: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 60: United Kingdom: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 61: Italy: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 62: Italy: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 63: Spain: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 64: Spain: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 65: Russia: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 66: Russia: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 67: Others: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 68: Others: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 69: Latin America: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 70: Latin America: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 71: Brazil: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 72: Brazil: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 73: Mexico: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 74: Mexico: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 75: Others: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 76: Others: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 77: Middle East and Africa: Atrial Fibrillation Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 78: Middle East and Africa: Atrial Fibrillation Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 79: Global: Atrial Fibrillation Industry: SWOT Analysis
  • Figure 80: Global: Atrial Fibrillation Industry: Value Chain Analysis
  • Figure 81: Global: Atrial Fibrillation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Atrial Fibrillation Market: Key Industry Highlights, 2019 and 2025
  • Table 2: Global: Atrial Fibrillation Market Forecast: Breakup by Devices (in Million US$), 2020-2025
  • Table 3: Global: Atrial Fibrillation Market Forecast: Breakup by Drug Class (in Million US$), 2020-2025
  • Table 4: Global: Atrial Fibrillation Market Forecast: Breakup by Application (in Million US$), 2020-2025
  • Table 5: Global: Atrial Fibrillation Market Forecast: Breakup by End-User (in Million US$), 2020-2025
  • Table 6: Global: Atrial Fibrillation Market Forecast: Breakup by Region (in Million US$), 2020-2025
  • Table 7: Global: Atrial Fibrillation Market Structure
  • Table 8: Global: Atrial Fibrillation Market: Key Players

The global atrial fibrillation treatment market grew at a CAGR of around 14% during 2014-2019. Atrial fibrillation (AFib) refers to a cardiac condition with irregular and rapid heart rate that increases the risks of stroke, heart failure and other heart-related complications. In this condition, the upper (atrial) chambers beat irregularly and out of coordination with the lower (ventricle) chambers of the heart, thereby causing heart palpitations, shortness of breath and fatigue. It can also lead to the development of blood clots that may disrupt the blood flow to other organs. The main types of AFib include paroxysmal, persistent, long-term persistent, and permanent AFib that can be treated with medications and other interventions to adjust the heart's electrical impulses.

The rising prevalence of cardiovascular diseases (CVDs) is one of the key factors driving the growth of the market. Such disorders are highly prevalent among the geriatric population and individuals suffering from other ailments, such as diabetes, hypertension and cardiovascular diseases (CVDs). This, along with the steadily increasing geriatric population across the globe, is providing a boost to the market growth. Furthermore, the increasing preference for minimally invasive (MI) surgical procedures is also creating a positive impact on the demand for miniaturized surgical devices, implant surgeries and remote nursing. Additionally, various technological advancements, such as the development of catheter ablation devices to remove damaged heart tissues and innovative mapping and recording systems, is acting as another growth-inducing factor. Other factors, including improvements in the healthcare infrastructure and extensive research and development (R&D) activities in the field of medical sciences, are projected to drive the market further. Looking forward, IMARC Group expects the market to continue its strong growth during the next five years.

Breakup by Disorder Type:

  • Paroxysmal Atrial Fibrillation
  • Persistent Atrial Fibrillation
  • Permanent Atrial Fibrillation
  • Others

Breakup by Treatment Type:

  • Medical Procedures
  • Surgical Procedures
  • Maze Surgery
  • Catheter Ablation
  • Non-Surgical Procedures
  • Electric Cardioversion
  • Diagnostic Catheters
  • Mapping and Recording Systems
  • Cardiac Monitors
  • Access Devices
  • Left Atrial Appendage and Closure Devices
  • Intracardiac Echocardiography (ICE) Systems
  • Medication
  • Anticoagulants
  • Anti-Arrhythmics

Breakup by End-User:

  • Hospitals
  • Cardiac Labs
  • Ambulatory Surgical Centers
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Atricure Inc., Biotronik, Boston Scientific Corporation, Cardiofocus Inc., Hansen Medical Inc. (Auris Health), Johnson & Johnson, Siemens Healthineers (Cerner Corporation), Stereotaxis Inc., etc.

Key Questions Answered in This Report:

  • How has the global atrial fibrillation treatment market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What is the breakup of the market based on the disorder type?
  • What is the breakup of the market based on the treatment type?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global atrial fibrillation market treatment and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Atrial Fibrillation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Market Forecast

6 Market Breakup by Disorder Type

  • 6.1 Paroxysmal Atrial Fibrillation
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Persistent Atrial Fibrillation
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Permanent Atrial Fibrillation
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Treatment Type

  • 7.1 Medical Procedures
    • 7.1.1 Market Trends
    • 7.1.2 Surgical Procedures
      • 7.1.2.1 Maze Surgery
      • 7.1.2.2 Catheter Ablation
    • 7.1.3 Non-Surgical Devices
      • 7.1.3.1 Electric Cardioversion
      • 7.1.3.2 Diagnostic Catheters
      • 7.1.3.3 Mapping and Recording Systems
      • 7.1.3.4 Cardiac Monitors
      • 7.1.3.5 Access Devices
      • 7.1.3.6 Left Atrial Appendage and Closure Devices
      • 7.1.3.7 Intracardiac Echocardiography (ICE) Systems
    • 7.1.4 Market Forecast
  • 7.2 Medications
    • 7.2.1 Market Trends
    • 7.2.2 Drug Classes
      • 7.2.2.1 Anticoagulants
      • 7.2.2.2 Anti-Arrhythmics
    • 7.2.3 Market Forecast

8 Market Breakup by End-User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cardiac Labs
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Ambulatory Surgical Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Atricure Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 Biosense Webster Inc.
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Biotronik
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 SWOT Analysis
    • 13.3.5 Cardiofocus Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
    • 13.3.6 Hansen Medical Inc. (Auris Health)
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
    • 13.3.7 Johnson & Johnson
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Siemens Healthineers (Cerner Corporation)
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
    • 13.3.9 Stereotaxis Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
Back to Top
전화 문의
F A Q